Patent · US Active

Reduced size self-delivering RNAI compounds

US11118178B2 · kind B2 · utility

4Cited by
215References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 7, 2019
Grant dateSep 14, 2021
Priority date—
Expiry dateFeb 7, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to methods for in vivo administration of sd-rxRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.